190005-91-5

Basic information

• Product Name: 3-Thiophenecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]methylamino]-, methyl ester
• CAS NO: 190005-91-5
• Molecular Formula: C12H17NO4S
• Molecular Weight: 271.337
• Mol File: 190005-91-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-Thiophenecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]methylamino]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Thiophenecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]methylamino]-, methyl ester(190005-91-5)
• EPA Substance Registry System: 3-Thiophenecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]methylamino]-, methyl ester(190005-91-5)

Safety Data

• Hazardous Substances Data: 190005-91-5(Hazardous Substances Data)

Upstream product

• 39978-14-8 methyl 3-amino-4-thiophenecarboxylate hydrochloride 
• 58230-46-9 4-hydroxyimino-tetrahydro-thiophene-3-carboxylic acid methyl ester 
• 2689-68-1 methyl 4-oxotetrahydrothiophene-3-carboxylate 
• 161940-20-1 methyl 4-((tert-butoxycarbonyl)amino)thiophene-3-carboxylate 
• 74-88-4 methyl iodide 

Relevant articles and documents

Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents

A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery. (Figure Presented).